Associate Professor of Urology and Oncology

Director of the Johns Hopkins Kidney Cancer Program

Co-Director of the Johns Hopkins Upper Tract Urothelial Cancer Program

Director of Translational Research in Genitourinary Oncology, Brady Urological Institute

Vice Chair for Quality, Safety, and Service, Brady Urological Institute

Research Interests:

• Biomarker discovery
• Clinical trials
• Kidney cancer
• Multimodal treatment
• Precision oncology
• Renal cell carcinoma
• Testicular cancer
• Translational research
• Upper tract urothelial carcinoma
• Urologic malignancies

Nirmish Singla is an associate professor of urology and oncology in the Brady Urological Institute at Johns Hopkins Medicine, where he also serves as the director of translational research in genitourinary (GU) oncology. He is also the director of the Kidney Cancer Program and co-directs the Upper Tract Urothelial Cancer (UTUC) Program as a founding member of the first-ever UTUC multidisciplinary clinic. Singla serves the Brady Institute in a leadership capacity as vice chair and physician advisor for quality, safety, and service; as faculty senator for the Department of Urology; and as a core faculty member of the Hopkins Business of Health Initiative. He also represents the Sidney Kimmel Comprehensive Cancer Center on its National Comprehensive Cancer Network Testicular Cancer Guidelines panel and helps lead the Testicular Cancer Program.

As both a surgeon-scientist and clinical trialist, Singla’s overarching goal is to help scientific discoveries in the laboratory materialize for patients with urologic cancers in the clinic. Clinically, he provides personalized and compassionate care for patients affected by urologic cancer by integrating cutting-edge technologies and multidisciplinary approaches to treatment across the full spectrum of urologic malignancies. He also leads a well-funded, multidisciplinary, and translational laboratory in urologic oncology. Singla has co-authored over 300 articles and textbook chapters, and he has developed an international reputation as a thought leader in urologic oncology. He serves as the lead principal investigator on multiple grants from federal, foundational, intramural, and private sources across various GU malignancies.

Singla received his BSE in biomedical engineering from the University of Michigan and his MD from the University of Michigan Medical School, where he was supported by a full-tuition Dean’s Merit Scholarship. He went on to complete his residency training in urologic surgery at the University of Texas Southwestern Medical Center (UTSW). Following his residency, he received a Ruth L. Kirschstein National Research Service Award (T32) from the National Institutes of Health/National Cancer Institute and spent an additional year at UTSW as a postdoctoral research fellow in urologic oncology with a specialized translational focus in kidney cancer through UTSW’s Physician Scientist Training Program. During this time, he earned a master of science in clinical science degree through the UTSW Center for Translational Medicine and helped develop and pioneer a physician administrative fellowship program. He then completed an advanced surgical fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York through the Society of Urologic Oncology before joining the Johns Hopkins faculty.